logo BDSP

Base documentaire

  1. Cost-effectiveness in the treatment of schizophrenia.

    Article, Communication - En anglais

    ECST : European Committee for Standardization of Clinical Trials with Psychotropics. Strasbourg FRA, 1994/05/26.

    This paper discusses the need for a health economics perspective and some of the central methodological issues raised by economic appraisals, including cost-effectiveness and cost-utility analyses.

    It illustrates how cost-effectiveness studies can inform policy and practice decisions concerning the treatment of schizophrenia, focusing on five generic evaluation questions commonly raised.

    Examples are drawn from recent and current UK research.

    Mots-clés Pascal : Royaume Uni, Europe, Analyse coût efficacité, Economie santé, Traitement, Schizophrénie, Psychose, Homme, Analyse coût utilité

    Mots-clés Pascal anglais : United Kingdom, Europe, Cost efficiency analysis, Health economy, Treatment, Schizophrenia, Psychosis, Human

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 96-0308089

    Code Inist : 002B18H05A. Création : 10/04/1997.